Analyst Bullish on Cogent (COGT) Amid Expected Drug Approval
Analyst Bullish on Cogent (COGT) Amid Expected Drug Approval Miko Ilas Sat, February 28, 2026 at 5:06 AM GMT+8 1 min read In this article: COGT -1.55% Cogent Biosciences Inc. (NASDAQ:COGT) is one of t...